Pure Global
NCT06120413

18F-LN1 PET/CT in Urothelial Carcinomas

Clinical Evaluation of 18F-LN1 PET/CT for Imaging of Nectin-4 in Urothelial Carcinomas
Sichuan Provincial People's Hospital·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Urothelial Carcinoma
Study type
Observational
Sponsor & location
Primary sponsor
Sichuan Provincial People's Hospital
Location
Chengdu, China
Timeline & enrollment
Phase
N/A
Start date
Nov 01, 2023
End date
Oct 01, 2024
Enrollment
30 participants
Primary outcome

Comparison of 18F-LN1 and 18F-FDG Uptake in Patients with urothelial carcinoma

Summary

The clinical feasibility of 18F-LN1 PET/CT will be evaluated in 30 patients with urothelial
 carcinoma, and the results will be compared with those of 18F-FDG.

ICD-10 classifications
Carcinoma in situ: Other and unspecified urinary organsMalignant neoplasm of ureterMalignant neoplasms of urinary tractMalignant neoplasm: Overlapping lesion of urinary organsMalignant neoplasm: Urethra
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06120413
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06120413 through Pure Global AI's free database. This phase not specified trial is sponsored by Sichuan Provincial People's Hospital and is currently Recruiting. The study focuses on Urothelial Carcinoma. Target enrollment is 30 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.